{"id":21577,"date":"2025-01-15T13:16:36","date_gmt":"2025-01-15T05:16:36","guid":{"rendered":"https:\/\/flcube.com\/?p=21577"},"modified":"2025-01-15T13:16:38","modified_gmt":"2025-01-15T05:16:38","slug":"medtronic-secures-exclusive-distribution-rights-for-contegos-neuroguard-and-excipio","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=21577","title":{"rendered":"Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio"},"content":{"rendered":"\n

US-Irish firm Medtronic (NYSE: MDT<\/a>) has entered into an exclusive distribution agreement with Contego Medical, becoming the sole US distributor for Contego’s portfolio of commercially available products. This includes the recently FDA-approved Neuroguard IEP System, a unique 3-in-1 carotid stenting system, and the Excipio Peripheral Thrombectomy Devices. These products are revascularization treatments for carotid and peripheral vascular diseases and are scheduled for distribution by Medtronic\u2019s peripheral vascular and neurovascular business team this Spring.<\/p>\n\n\n\n

Neuroguard IEP System and Excipio Devices<\/strong>
The Neuroguard IEP System is a groundbreaking 3-in-1 carotid stenting system designed to improve patient outcomes in carotid artery disease. The Excipio Peripheral Thrombectomy Devices are advanced tools for the treatment of peripheral vascular diseases. Both products represent significant advancements in the field of vascular interventions, offering healthcare providers more effective treatment options for their patients.<\/p>\n\n\n\n

Medtronic’s Investment and Acquisition Option<\/strong>
Medtronic, which has held a minority ownership in Contego since 2020, will make an increased investment in the company. This strategic move also includes an acquisition option, highlighting Medtronic’s commitment to expanding its product portfolio and enhancing its position in the vascular intervention market. By integrating Contego’s innovative products, Medtronic aims to strengthen its offerings and provide comprehensive solutions for carotid and peripheral vascular diseases.<\/p>\n\n\n\n

Strategic Implications for Medtronic<\/strong>
This exclusive distribution agreement and increased investment in Contego underscore Medtronic’s strategy to lead in the development and delivery of advanced medical technologies. By bringing Contego’s products to market, Medtronic will further solidify its role as a key player in the vascular intervention space, offering healthcare providers and patients access to cutting-edge treatments.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical,…<\/p>\n","protected":false},"author":1,"featured_media":21579,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[3153,233,1031],"class_list":["post-21577","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-medical-device","tag-contego-medical","tag-medtronic","tag-nyse-mdt"],"yoast_head":"\nMedtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical, becoming the sole US distributor for Contego's portfolio of commercially available products. This includes the recently FDA-approved Neuroguard IEP System, a unique 3-in-1 carotid stenting system, and the Excipio Peripheral Thrombectomy Devices. These products are revascularization treatments for carotid and peripheral vascular diseases and are scheduled for distribution by Medtronic\u2019s peripheral vascular and neurovascular business team this Spring.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=21577\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio\" \/>\n<meta property=\"og:description\" content=\"US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical, becoming the sole US distributor for Contego's portfolio of commercially available products. This includes the recently FDA-approved Neuroguard IEP System, a unique 3-in-1 carotid stenting system, and the Excipio Peripheral Thrombectomy Devices. These products are revascularization treatments for carotid and peripheral vascular diseases and are scheduled for distribution by Medtronic\u2019s peripheral vascular and neurovascular business team this Spring.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=21577\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T05:16:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-15T05:16:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1508.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"394\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio\",\"datePublished\":\"2025-01-15T05:16:36+00:00\",\"dateModified\":\"2025-01-15T05:16:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577\"},\"wordCount\":283,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1508.png\",\"keywords\":[\"Contego Medical\",\"Medtronic\",\"NYSE: MDT\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=21577#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=21577\",\"name\":\"Medtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1508.png\",\"datePublished\":\"2025-01-15T05:16:36+00:00\",\"dateModified\":\"2025-01-15T05:16:38+00:00\",\"description\":\"US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical, becoming the sole US distributor for Contego's portfolio of commercially available products. This includes the recently FDA-approved Neuroguard IEP System, a unique 3-in-1 carotid stenting system, and the Excipio Peripheral Thrombectomy Devices. These products are revascularization treatments for carotid and peripheral vascular diseases and are scheduled for distribution by Medtronic\u2019s peripheral vascular and neurovascular business team this Spring.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=21577\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1508.png\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1508.png\",\"width\":1080,\"height\":394,\"caption\":\"Medtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21577#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio - Insight, China's Pharmaceutical Industry","description":"US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical, becoming the sole US distributor for Contego's portfolio of commercially available products. This includes the recently FDA-approved Neuroguard IEP System, a unique 3-in-1 carotid stenting system, and the Excipio Peripheral Thrombectomy Devices. These products are revascularization treatments for carotid and peripheral vascular diseases and are scheduled for distribution by Medtronic\u2019s peripheral vascular and neurovascular business team this Spring.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=21577","og_locale":"en_US","og_type":"article","og_title":"Medtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio","og_description":"US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical, becoming the sole US distributor for Contego's portfolio of commercially available products. This includes the recently FDA-approved Neuroguard IEP System, a unique 3-in-1 carotid stenting system, and the Excipio Peripheral Thrombectomy Devices. These products are revascularization treatments for carotid and peripheral vascular diseases and are scheduled for distribution by Medtronic\u2019s peripheral vascular and neurovascular business team this Spring.","og_url":"https:\/\/flcube.com\/?p=21577","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-01-15T05:16:36+00:00","article_modified_time":"2025-01-15T05:16:38+00:00","og_image":[{"width":1080,"height":394,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1508.png","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=21577#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=21577"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio","datePublished":"2025-01-15T05:16:36+00:00","dateModified":"2025-01-15T05:16:38+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=21577"},"wordCount":283,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=21577#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1508.png","keywords":["Contego Medical","Medtronic","NYSE: MDT"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=21577#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=21577","url":"https:\/\/flcube.com\/?p=21577","name":"Medtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=21577#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=21577#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1508.png","datePublished":"2025-01-15T05:16:36+00:00","dateModified":"2025-01-15T05:16:38+00:00","description":"US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical, becoming the sole US distributor for Contego's portfolio of commercially available products. This includes the recently FDA-approved Neuroguard IEP System, a unique 3-in-1 carotid stenting system, and the Excipio Peripheral Thrombectomy Devices. These products are revascularization treatments for carotid and peripheral vascular diseases and are scheduled for distribution by Medtronic\u2019s peripheral vascular and neurovascular business team this Spring.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=21577#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=21577"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=21577#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1508.png","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1508.png","width":1080,"height":394,"caption":"Medtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=21577#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1508.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21577"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21577\/revisions"}],"predecessor-version":[{"id":21580,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21577\/revisions\/21580"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/21579"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}